Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Question

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Oct 25, 2023 12:02am

178 Views

Post# 35699434

RE:RE:RE:RE:Question

Yes essentially $3 US = $4.00 Cdn per share. And based on 1/3 of a billion shares o/s.

Makes sense, although perhaps a tiny bit low on buyout price, relative to true valuation and potential ( much is dependent on final Tigris results and mortality benefit, Eden results, etc. all of which likely impacts future PMX price, disposition of the FDA approved companion diagnostic, iDialco, etc.)

Question for you . How easy is it to trade on OTC and or for other American investors to discover Spectral and to understand its potential?

MM

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features